<ul><li>Cambridge Innovation Capital (CIC) has launched a £100 million ($126 million) 'Opportunity Fund' to address the funding gap for later-stage startups in the UK.</li><li>The fund is being anchored by Aviva Investors and British Patient Capital and will invest in growth-stage deep tech and life sciences companies.</li><li>CIC has already made two investments through the fund, including Pragmatic Semiconductor and Riverlane.</li><li>The new fund aims to retain later-stage startups in the UK and prevent them from seeking funding in other countries, such as the US.</li></ul>

Key Cambridge, UK VC launches $126M fund to stem later stage flight

Discover more